131 related articles for article (PubMed ID: 15128841)
1. The novel cyclophilin-binding drug sanglifehrin A specifically affects antigen uptake receptor expression and endocytic capacity of human dendritic cells.
Woltman AM; Schlagwein N; van der Kooij SW; van Kooten C
J Immunol; 2004 May; 172(10):6482-9. PubMed ID: 15128841
[TBL] [Abstract][Full Text] [Related]
2. Cutting edge: sanglifehrin A, a novel cyclophilin-binding immunosuppressant blocks bioactive IL-12 production by human dendritic cells.
Steinschulte C; Taner T; Thomson AW; Bein G; Hackstein H
J Immunol; 2003 Jul; 171(2):542-6. PubMed ID: 12847216
[TBL] [Abstract][Full Text] [Related]
3. The cyclophilin-binding agent Sanglifehrin A is a dendritic cell chemokine and migration inhibitor.
Immecke SN; Baal N; Wilhelm J; Bechtel J; Knoche A; Bein G; Hackstein H
PLoS One; 2011 Mar; 6(3):e18406. PubMed ID: 21483789
[TBL] [Abstract][Full Text] [Related]
4. Dentritic cell derived IL-18 production is inhibited by rapamycin and sanglifehrin A, but not cyclosporine A.
Ko H; Hambly BD; Eris JM; Levidiotis V; Wyburn K; Wu H; Chadban SJ; Yin JL
Transpl Immunol; 2008 Nov; 20(1-2):99-105. PubMed ID: 18662782
[TBL] [Abstract][Full Text] [Related]
5. Sanglifehrin A, a novel cyclophilin-binding compound showing immunosuppressive activity with a new mechanism of action.
Zenke G; Strittmatter U; Fuchs S; Quesniaux VF; Brinkmann V; Schuler W; Zurini M; Enz A; Billich A; Sanglier JJ; Fehr T
J Immunol; 2001 Jun; 166(12):7165-71. PubMed ID: 11390463
[TBL] [Abstract][Full Text] [Related]
6. Sanglifehrin A, a novel cyclophilin-binding immunosuppressant, inhibits IL-2-dependent T cell proliferation at the G1 phase of the cell cycle.
Zhang LH; Liu JO
J Immunol; 2001 May; 166(9):5611-8. PubMed ID: 11313401
[TBL] [Abstract][Full Text] [Related]
7. Cyclophilin sensitivity to sanglifehrin A can be correlated to the same specific tryptophan residue as cyclosporin A.
Pemberton TJ; Kay JE
FEBS Lett; 2003 Dec; 555(2):335-40. PubMed ID: 14644438
[TBL] [Abstract][Full Text] [Related]
8. Cyclic nucleotides promote monocyte differentiation toward a DC-SIGN+ (CD209) intermediate cell and impair differentiation into dendritic cells.
Giordano D; Magaletti DM; Clark EA; Beavo JA
J Immunol; 2003 Dec; 171(12):6421-30. PubMed ID: 14662841
[TBL] [Abstract][Full Text] [Related]
9. Immunosuppressive activity of the immunophilin-binding drug Sanglifehrin A in human whole blood: potent inhibition of interleukin-6 produced by lymphocytes and monocytes.
Härtel C; Iblher P; Puzik A; Wortmeier K; Ebel B; Schultz C; Müller-Steinhardt M
Scand J Immunol; 2006 Jan; 63(1):26-34. PubMed ID: 16398698
[TBL] [Abstract][Full Text] [Related]
10. Glucocorticoids affect human dendritic cell differentiation and maturation.
Piemonti L; Monti P; Allavena P; Sironi M; Soldini L; Leone BE; Socci C; Di Carlo V
J Immunol; 1999 Jun; 162(11):6473-81. PubMed ID: 10352262
[TBL] [Abstract][Full Text] [Related]
11. Expression of multilectin receptors and comparative FITC-dextran uptake by human dendritic cells.
Kato M; Neil TK; Fearnley DB; McLellan AD; Vuckovic S; Hart DN
Int Immunol; 2000 Nov; 12(11):1511-9. PubMed ID: 11058570
[TBL] [Abstract][Full Text] [Related]
12. Human lung dendritic cells have an immature phenotype with efficient mannose receptors.
Cochand L; Isler P; Songeon F; Nicod LP
Am J Respir Cell Mol Biol; 1999 Nov; 21(5):547-54. PubMed ID: 10536111
[TBL] [Abstract][Full Text] [Related]
13. Differential expression and function of IgA receptors (CD89 and CD71) during maturation of dendritic cells.
Pasquier B; Lepelletier Y; Baude C; Hermine O; Monteiro RC
J Leukoc Biol; 2004 Dec; 76(6):1134-41. PubMed ID: 15371488
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of cell cycle progression by the novel cyclophilin ligand sanglifehrin A is mediated through the NFkappa B-dependent activation of p53.
Zhang LH; Youn HD; Liu JO
J Biol Chem; 2001 Nov; 276(47):43534-40. PubMed ID: 11557753
[TBL] [Abstract][Full Text] [Related]
15. The novel cyclophilin binding compound, sanglifehrin A, disassociates G1 cell cycle arrest from tolerance induction.
Allen A; Zheng Y; Gardner L; Safford M; Horton MR; Powell JD
J Immunol; 2004 Apr; 172(8):4797-803. PubMed ID: 15067056
[TBL] [Abstract][Full Text] [Related]
16. C-reactive protein impairs human CD14+ monocyte-derived dendritic cell differentiation, maturation and function.
Zhang R; Becnel L; Li M; Chen C; Yao Q
Eur J Immunol; 2006 Nov; 36(11):2993-3006. PubMed ID: 17051617
[TBL] [Abstract][Full Text] [Related]
17. Heparin induces differentiation of CD1a+ dendritic cells from monocytes: phenotypic and functional characterization.
Xia CQ; Kao KJ
J Immunol; 2002 Feb; 168(3):1131-8. PubMed ID: 11801647
[TBL] [Abstract][Full Text] [Related]
18. Split activity of interleukin-10 on antigen capture and antigen presentation by human dendritic cells: definition of a maturative step.
Morel AS; Quaratino S; Douek DC; Londei M
Eur J Immunol; 1997 Jan; 27(1):26-34. PubMed ID: 9021994
[TBL] [Abstract][Full Text] [Related]
19. Aspirin inhibits in vitro maturation and in vivo immunostimulatory function of murine myeloid dendritic cells.
Hackstein H; Morelli AE; Larregina AT; Ganster RW; Papworth GD; Logar AJ; Watkins SC; Falo LD; Thomson AW
J Immunol; 2001 Jun; 166(12):7053-62. PubMed ID: 11390449
[TBL] [Abstract][Full Text] [Related]
20. A comparison between isolated blood dendritic cells and monocyte-derived dendritic cells in pigs.
Facci MR; Auray G; Buchanan R; van Kessel J; Thompson DR; Mackenzie-Dyck S; Babiuk LA; Gerdts V
Immunology; 2010 Mar; 129(3):396-405. PubMed ID: 19922422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
